Evaluation of SpO2 Measurement Using a Smartwatch

NCT ID: NCT04780724

Last Updated: 2022-01-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-02-15

Study Completion Date

2021-03-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to compare the measurement of peripheral blood oxygen saturation using a smartwatch with a medical-grade pulse oximeter.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Recently, wearables, like smartwatches, have been gaining new possibilities in monitoring biological signals and they are used for home monitoring of health conditions. The newest models of smartwatches even measure peripheral blood oxygen saturation (SpO2). The study aims to compare the measurement of peripheral blood oxygen saturation using the latest smartwatch with a medical-grade pulse oximeter under the condition of normobaric hypoxia. Healthy participants will breathe oxygen-reduced mixtures (the hypoxic gas mixture of 12% O2 and 88% N2 and the hypercapnic and hypoxic gas mixture of 12% O2, 5% CO2, and 83% N2), which will temporarily reduce their blood oxygen saturation. SpO2 measurements will be taken by hand from the watch and the pulse oximeter simultaneously. The agreement of the measurements of both devices will be evaluated.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypoxia Hypercapnia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

All participants go through all study arms, in random order. Two measuring devices are active simultaneously during measurement on each participant and their functioning is compared.
Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hypoxic

Participants inhale ambient air, the hypoxic gas mixture, and ambient air.

Group Type EXPERIMENTAL

Hypoxic gas mixture

Intervention Type OTHER

Gas mixture of 12% O2 and 88% N2 for five minutes.

SpO2 measurement

Intervention Type OTHER

Two SpO2 measuring devices are active simultaneously during measurement.

Hypercapnic

Participants inhale ambient air, the hypercapnic and hypoxic gas mixture, and the ambient air.

Group Type EXPERIMENTAL

Hypercapnic and hypoxic gas mixture

Intervention Type OTHER

Gas mixture of 12% O2, 5% CO2, and 88% N2 for five minutes.

SpO2 measurement

Intervention Type OTHER

Two SpO2 measuring devices are active simultaneously during measurement.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hypoxic gas mixture

Gas mixture of 12% O2 and 88% N2 for five minutes.

Intervention Type OTHER

Hypercapnic and hypoxic gas mixture

Gas mixture of 12% O2, 5% CO2, and 88% N2 for five minutes.

Intervention Type OTHER

SpO2 measurement

Two SpO2 measuring devices are active simultaneously during measurement.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* healthy volunteers from the Czech Technical University

Exclusion Criteria

* pregnancy
* severe cardiovascular conditions
* severe asthma or other severe respiratory conditions
* injury to the upper limbs or hands that could affect the peripheral perfusion
* diabetes
* hypotension or hypertension
Minimum Eligible Age

18 Years

Maximum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Czech Technical University in Prague

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Veronika Rafl Huttova

Role: PRINCIPAL_INVESTIGATOR

Czech Technical University in Prague

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Biomedical Engineering, Czech Technical University in Prague

Kladno, , Czechia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Czechia

References

Explore related publications, articles, or registry entries linked to this study.

Rafl J, Kulhanek F, Kudrna P, Ort V, Roubik K. Response time of indirectly accessed gas exchange depends on measurement method. Biomed Tech (Berl). 2018 Nov 27;63(6):647-655. doi: 10.1515/bmt-2017-0070.

Reference Type BACKGROUND
PMID: 28802098 (View on PubMed)

Lauterbach CJ, Romano PA, Greisler LA, Brindle RA, Ford KR, Kuennen MR. Accuracy and Reliability of Commercial Wrist-Worn Pulse Oximeter During Normobaric Hypoxia Exposure Under Resting Conditions. Res Q Exerc Sport. 2021 Sep;92(3):549-558. doi: 10.1080/02701367.2020.1759768. Epub 2020 Jul 7.

Reference Type BACKGROUND
PMID: 32633688 (View on PubMed)

Rafl J, Bachman TE, Rafl-Huttova V, Walzel S, Rozanek M. Commercial smartwatch with pulse oximeter detects short-time hypoxemia as well as standard medical-grade device: Validation study. Digit Health. 2022 Oct 11;8:20552076221132127. doi: 10.1177/20552076221132127. eCollection 2022 Jan-Dec.

Reference Type DERIVED
PMID: 36249475 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

smartwatch21

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

WatchPAT SpO2 Validation Study
NCT06947447 COMPLETED